“Welcome to the Greencare Capital plc website. We are an investment company seeking to take advantage of the rapidly changing regulatory environment surrounding legal Medicinal Cannabis, the HEMP and CBD Wellness sectors and other plant-based medicines. The Company has a number of pipeline investment opportunities currently being appraised, predominantly in Europe, and our investment strategy will focus on markets that are recognised as having well-developed and reputable laws and regulations relating to the research and production of Cannabis and related products.”
Fabio Carretta CEO Greencare Capital plc
Admission to the NEX Exchange Growth Market
The Company announced on Tuesday 17 December that it is seeking Admission of its entire issued share capital, as enlarged by way of a recent share subscription, to the NEX Exchange Growth Market. It is anticipated that Admission will become effective and dealings in the Company’s Ordinary Shares will commence on 30 December.